<DOC>
	<DOCNO>NCT00022204</DOCNO>
	<brief_summary>RATIONALE : Vitamin E pentoxifylline may effective decrease lymphedema woman receive radiation therapy breast cancer . PURPOSE : Randomized phase II trial determine effectiveness combine vitamin E pentoxifylline treat woman lymphedema receive radiation therapy breast cancer .</brief_summary>
	<brief_title>Vitamin E Pentoxifylline Treating Women With Lymphedema After Radiation Therapy Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect vitamin E pentoxifylline lymphedema patient previously treat radiotherapy breast cancer . II . Compare normal tissue injury quality life patient treat regimen vs placebo . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients randomize one two treatment arm . Arm I : Patients receive oral vitamin E oral pentoxifylline twice daily 6 month . Arm II : Patients receive oral placebo twice daily 6 month . Quality life assess baseline 3 , 6 , 9 , 12 month . Patients follow 6 12 month . PROJECTED ACCRUAL : A total 100 patient ( 50 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior diagnosis breast cancer T13 , N01 , M0 Prior radiotherapy breast/chest wall plus axilla and/or supraclavicular fossa At least 2 year since prior radiotherapy No disease recurrence Arm lymphedema due prior radiotherapy Reduced shoulder movement , induration breast/chest wall , radiationinduced brachial plexopathy , symptomatic lung fibrosis , nonhealing wound ( include fracture ) allow evidence disability addition arm lymphedema Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Not specify Sex : Female male Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : No liver failure Renal : No renal failure Cardiovascular : No ischemic heart disease No hypertension No hypotension No acute myocardial infarction No prior cerebral hemorrhage No prior retinal hemorrhage Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No allergy coconut oil PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent insulin Radiotherapy : See Disease Characteristics Surgery : No prior axillary surgery Lower axillary sampling allow Other : At least 3 month since prior daily vitamin E supplementation 30 mg/day No prior pentoxifylline radiotherapy No concurrent ketorolac vitamin K No concurrent vitamin E supplementation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>lymphedema</keyword>
	<keyword>male breast cancer</keyword>
</DOC>